bibliografie

2
Bibliografie: 1. M. VAUBELLE, E. TELLER AND M. FOCANT, 1990, Probiotics in animal nutrition, Arch. Anim. Nutr., 40, 543 – 567. 2. GEDEK B., 1987, Feed Mag. Int., Nov. 21. 3. RAIBAND P., RAYNAUD C., 1989, 6 - éme SIMAVIP, Eds., AFMVP., 9 – 31. 4. CHAN R., G. REID, BRUCE A.W., CESTERTON W., 1984, Applied and Enviromental Microbiol., 48, 1159. 5. LEE A., 1980, Normal flora of intestinal surfaces, in Absorption of Microorganisms to surfaces, John Wiley, New York. 6. ANTOINE, 1989, Propriétés physiologique des laits fermentés vivants, In Séminairs agro-alimèntaires a Louvain-Neuve. 7. BERGONE-BEREZIU, E., 1995, Impact ecologique de l’antibiothérapie, La Press Medicale, 24, 145-56. 8. CORBAN C., RICHARD A., BONS B., 1994, Les colites pseudomembranaise associès a l’antibiothérapie, Therapie, 49, 325-31. 9. COSTEX F., CARTHIER G. JOUVERT F., ELMER W.G., LUCS F., 1990, Prevention of Clostridium difficile induced experimental pseudomembranous calitis by Saccharomyces boulardii, J. Gen. Microbiol., 1085-9. 10. DUCLUZEAU R., BENSAADA M., 1982, Effect comparé de l’administration unique on en continu de Saccharomyces boulardii sur l’éstablishment de diverses souches de Candida dans le tractus digestif de souris gnotoxéniques, Ann. Microbiol. (I. Pasteur), 133B, 491-501. 11. SURAWICZ C.M., MAC FARLAND W., ELMER G., CHINN M.D., 1989, Treatment of recurrent Clostridium difficile calitis with vancomycin and Saccharomyces boulardii, Am. J. Gastroenterol, 1285-7. 12. BERG R., BERNASCONI P., FOWLER D., GAUTREUX M., 1993, Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii, J. Infect. Dis., 168, 1314- 8. 1. Banu c. - biotehnologii în industria alimentară, editura tehnică - bucureşti,1987. 2. Banu c. – ‘manualul inginerului de industrie alimentară”, ed. Tehnică, vol i şi ii bucureşti,1998 . 3. Banu c., georgescu gh., mărgineanu gh., pasat gh.d., - cartea producătorului şi procesatorului de lapte, vol.iv, ed. Ceres - buc.,2005.

Upload: olga-bucatari

Post on 13-Sep-2015

215 views

Category:

Documents


1 download

DESCRIPTION

jhb

TRANSCRIPT

Bibliografie:

1. M. VAUBELLE, E. TELLER AND M. FOCANT, 1990, Probiotics in animal nutrition, Arch. Anim. Nutr., 40, 543 567. 2. GEDEK B., 1987, Feed Mag. Int., Nov. 21. 3. RAIBAND P., RAYNAUD C., 1989, 6 - me SIMAVIP, Eds., AFMVP., 9 31. 4. CHAN R., G. REID, BRUCE A.W., CESTERTON W., 1984, Applied and Enviromental Microbiol., 48, 1159. 5. LEE A., 1980, Normal flora of intestinal surfaces, in Absorption of Microorganisms to surfaces, John Wiley, New York. 6. ANTOINE, 1989, Proprits physiologique des laits ferments vivants, In Sminairs agro-alimntaires a Louvain-Neuve. 7. BERGONE-BEREZIU, E., 1995, Impact ecologique de lantibiothrapie, La Press Medicale, 24, 145-56. 8. CORBAN C., RICHARD A., BONS B., 1994, Les colites pseudomembranaise associs a lantibiothrapie, Therapie, 49, 325-31. 9. COSTEX F., CARTHIER G. JOUVERT F., ELMER W.G., LUCS F., 1990, Prevention of Clostridium difficile induced experimental pseudomembranous calitis by Saccharomyces boulardii, J. Gen. Microbiol., 1085-9. 10. DUCLUZEAU R., BENSAADA M., 1982, Effect compar de ladministration unique on en continu de Saccharomyces boulardii sur lstablishment de diverses souches de Candida dans le tractus digestif de souris gnotoxniques, Ann. Microbiol. (I. Pasteur), 133B, 491-501.

11. SURAWICZ C.M., MAC FARLAND W., ELMER G., CHINN M.D., 1989, Treatment of recurrent Clostridium difficile calitis with vancomycin and Saccharomyces boulardii, Am. J. Gastroenterol, 1285-7. 12. BERG R., BERNASCONI P., FOWLER D., GAUTREUX M., 1993, Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii, J. Infect. Dis., 168, 1314-8.

1. Banu c. - biotehnologii n industria alimentar, editura tehnic - bucureti,1987.2. Banu c. manualul inginerului de industrie alimentar, ed. Tehnic, vol i i ii bucureti,1998 .3. Banu c., georgescu gh., mrgineanu gh., pasat gh.d., - cartea productorului i procesatorului de lapte, vol.iv, ed. Ceres - buc.,2005.

1. Harish, K.,Varghese, T., (2006), Probiotics in humans evidence based review, Calicut Medical Journal;4(4):e32. 2. Bianchi-Salvadori, B. 1996 Selection of probiotic lactic acid bacteria on the basis of some physiological activities. IDF Nutrition Newsletter No. 145, 19-23

6. Costin, G.M. Produse lactate funcionale Bulet. Inf. Ind. Lapt 3, 117-1337. Costin, G.M., Segal, B., Segal, R. Tehnologia produselor destinate alimentaiei copiilor, Ed Tehnic, Bucureti

1. Viorica Maria Macovi,Calcule de operatii si utilaje pentru procesarea termic si biochimic in biotehnologie,Editura Alma,Galati ,20012. Gabriela Bahrim, Biotehnologia Preparatelor Enzimatice, Editura ACADEMICA, Galati, 20023. Jurcoane, Tratat de biotehnologie , vol. 1, Editura Tehnica, Bucuresti, 20044. G. Zarnea, Bioingineria preparatelor enzimatice microbiene, Editura Tehnica, Bucuresti 5. Dabija A., Rusu L.,Alexa I.C. ,Enzimologie industriala ,Editura Alma Mater ,Bacau,2007.

19. Spellberg B., Bartlett J.G., Gilbert D.N., 2013, The Future of Antibiotics and Resistance, N Engl J Med; 368:299-302.